EU clears Mylan's purchase of Pfizer's Upjohn unit with conditions

BRUSSELS (Reuters) - The European Commission said on Wednesday it had approved generic drugmaker Mylan NV's planned purchase of Pfizer's off-patient branded drugs business Upjohn, subject to conditions.The Commission, which oversees competition policy in the European Union, said its investigation had focused on genericised medicines, which are sold to pharmacies and hospitals, with overlaps in a number of fields.Mylan and Upjohn have offered to divest Mylan's certain generic medicines across..